PAM
AZN icon

Paradigm Asset Management’s AstraZeneca AZN Stock Holding History

Paradigm Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-600
Closed -$110K – 426
2025
Q4 		$110K Hold
600
– – 0.03% 332
2025
Q3 		$92.1K Hold
600
– – 0.02% 338
2025
Q2 		$83.9K Hold
600
– – 0.02% 344
2025
Q1 		$88.2K Hold
600
– – 0.02% 341
2024
Q4 		$78.6K Sell
600
-100
-14% -$14K 0.02% 343
2024
Q3 		$109K Sell
700
-100
-13% -$16.1K 0.03% 321
2024
Q2 		$125K Hold
800
– – 0.03% 301
2024
Q1 		$108K Hold
800
– – 0.03% 341
2023
Q4 		$108K Hold
800
– – 0.03% 340
2023
Q3 		$108K Buy
800
+200
+33% +$27.3K 0.03% 339
2023
Q2 		$85.9K Hold
600
– – 0.02% 350
2023
Q1 		$83.3K Hold
600
– – 0.02% 368
2022
Q4 		$81.4K Hold
600
– – 0.02% 380
2022
Q3 		$65.8K Buy
+600
New +$76.1K 0.02% 370
2022
Q2 		– Sell
-1,727
Closed -$229K – 398
2022
Q1 		$229K Hold
1,727
– – 0.06% 282
2021
Q4 		$201K Sell
1,727
-250
-13% -$29.4K 0.05% 297
2021
Q3 		$237K Buy
+1,977
New +$230K 0.07% 294
2014
Q3 		– Sell
-700
Closed -$52K – 787
2014
Q2 		$52K Hold
700
– – 0.01% 722
2014
Q1 		$45.4K Sell
700
-200
-22% -$12.9K 0.01% 710
2013
Q4 		$53.4K Hold
900
– – 0.01% 683
2013
Q3 		$46.7K Sell
900
-1,400
-61% -$70.3K 0.01% 714
2013
Q2 		$109K Buy
+2,300
New +$117K 0.02% 559

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Paradigm Asset Management's AZN Position: Q1 2026 in Review

Paradigm Asset Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 600 shares — an estimated $110K sold.

Paradigm Asset Management first reported a position in AZN in Q2 2013 and held it in 22 quarters. The position peaked at $237K in Q3 2021. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Paradigm Asset Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Paradigm Asset Management sold 600 AstraZeneca shares in Q1 2026, an estimated $110K.
  • Paradigm Asset Management first reported a position in AstraZeneca in Q2 2013 and held it in 22 quarters.
  • Paradigm Asset Management's AstraZeneca position peaked at $237K in Q3 2021.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Paradigm Asset Management's 13F filing for Q1 2026, filed 12 May 2026.